Silo Pharma (SILO) Interest & Investment Income (2017 - 2026)
Silo Pharma (SILO) posted Interest & Investment Income of $38718.0 for Q1 2026, down 9.03% sequentially from $42563.0 in Q4 2025, and up 367.33% YoY from $8285.0 in Q1 2025.
Silo Pharma (SILO) Interest & Investment Income (2017 - 2026) Analysis & Trends
Silo Pharma has reported Interest & Investment Income for 9 years, with the latest figure at $38718.0 in Q1 2026.
- Quarterly Interest & Investment Income rose 367.33% year-over-year to $38718.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $127979.0 (up 279.63% YoY) and the FY2025 annual result came in at $193912.0, up 2142.79% from the prior year.
- Interest & Investment Income eased to $38718.0 in Q1 2026 per SILO's latest filing, from $42563.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $116178.0 in Q3 2023 and troughed at -$296377.0 in Q4 2023.
- A 5-year average of $9484.8 and a median of $40640.5 in 2025 frame the typical range for Interest & Investment Income.
- The widest YoY moves for Interest & Investment Income: up 28967.37% in 2023, down 518.23% in 2023.
- Over 5 years, Interest & Investment Income stood at $70864.0 in 2022, then tumbled by 518.23% to -$296377.0 in 2023, then gained by 18.51% to -$241513.0 in 2024, then surged by 117.62% to $42563.0 in 2025, then slipped by 9.03% to $38718.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $38718.0, $42563.0, and $1781.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - | 39,155.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39,155.00 |
| Mar 31, 2026 | 38,718.00 |
| Dec 31, 2025 | 42,563.00 |
| Sep 30, 2025 | 1,781.00 |
| Jun 30, 2025 | 44,917.00 |
| Mar 31, 2025 | 8,285.00 |
| Dec 31, 2024 | -241,513.00 |
| Sep 30, 2024 | 84,940.00 |
| Jun 30, 2024 | 77,042.00 |
| Mar 31, 2024 | 88,177.00 |
| Dec 31, 2023 | -296,377.00 |
| Sep 30, 2023 | 116,178.00 |
| Jun 30, 2023 | 109,584.00 |
| Mar 31, 2023 | 5,239.00 |
| Dec 31, 2022 | 70,864.00 |
| Sep 30, 2022 | 981.00 |
| Jun 30, 2022 | 377.00 |
| Dec 31, 2020 | 2,755.00 |
| Sep 30, 2020 | 2,818.00 |
| Jun 30, 2020 | 2,937.00 |